Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EDTA induced changes in platelet structure and function: influence on particle uptake.

J G White1, M D Krumwiede, G Escolar

  • 1University of Minnesota Medical School Department of Laboratory Medicine, 420 Delaware Street S.E., Minneapolis, MN 55455, USA.

Platelets
|June 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A freeze-dried platelet-derived hemostatic agent improves hemostasis in patients with severe thrombocytopenia before and after standard platelet transfusion: Studies ex vivo in the total thrombus-formation analysis system 01.

Transfusion·2026
Same author

Diagnostic challenges in von Willebrand disease. Report of two cases with emphasis on multimeric and molecular analysis.

Platelets·2020
Same author

Towards the understanding of the UV light, riboflavin and additive solution contributions to the in vitro lesions observed in Mirasol®-treated platelets.

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine·2019
Same author

Emicizumab for routine prophylaxis to prevent bleeding episodes in patients with hemophilia A.

Drugs of today (Barcelona, Spain : 1998)·2018
Same author

Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor: comment.

Journal of thrombosis and haemostasis : JTH·2018
Same author

Betrixaban: a direct oral inhibitor of activated factor X for the prophylaxis of venous thromboembolism in patients hospitalized for acute medical illness.

Drugs of today (Barcelona, Spain : 1998)·2017
Same journal

Hexokinase controls platelet activation and hemostasis.

Platelets·2026
Same journal

Chemiluminescence resonance energy transfer-based method to investigate the platelet surface molecule in acute myocardial infarction.

Platelets·2026
Same journal

Nanobodies to GPVI as alternative reagents for platelet spreading.

Platelets·2026
Same journal

Neural network reveals platelet age from fluorescence microscopy images.

Platelets·2026
Same journal

Sixty years of research into ancestry differences in platelet function.

Platelets·2026
Same journal

Platelet-rich plasma concentrations regulate MSCs osteogenesis via MAPK/PI3K-AKT pathways to mitigate inflammatory bone loss.

Platelets·2026
See all related articles

Ethylenediaminetetraacetic acid (EDTA) damages blood platelets irreversibly. However, platelets treated with EDTA can still interact with particles, suggesting some functions remain intact despite structural changes.

Area of Science:

  • Hematology
  • Biochemistry
  • Cell Biology

Background:

  • Ethylenediaminetetraacetic acid (EDTA) is known to cause structural and functional damage to blood platelets.
  • These EDTA-induced alterations are generally considered irreversible.
  • The extent of irreversibility and the impact on various platelet functions require further investigation.

Purpose of the Study:

  • To evaluate the degree of irreversibility of EDTA-induced platelet damage.
  • To determine if all platelet functions are equally compromised by EDTA exposure.
  • To assess the ability of EDTA-treated platelets to interact with suspended particulates.

Main Methods:

  • Platelets were treated with EDTA to induce structural changes, particularly in the open canalicular system (OCS).

Related Experiment Videos

  • The study examined the dissociation of the fibrinogen receptor, GPIIb-IIIa (alpha(IIb)beta(3)).
  • The interaction of EDTA-treated platelets with fibrinogen-coated gold particles (Fgn/Au), colloidal gold, and latex spheres was assessed.

    • Main Results:

    • EDTA treatment led to severe narrowing and near occlusion of peripheral OCS channels.
    • Despite structural damage, EDTA-treated platelets demonstrated the ability to bind, translocate, and internalize Fgn/Au particles.
    • These platelets also interacted with colloidal gold and latex spheres.

    Conclusions:

    • EDTA exposure causes significant structural damage to platelet OCS channels.
    • EDTA treatment does not completely abolish platelet interaction with certain particulates.
    • Some platelet functions may be preserved despite EDTA-induced damage, potentially impacting hemostatic roles.